DaVita (NYSE:DVA) (NYSE:DVA) is a leading provider of kidney care services, specializing in outpatient dialysis for patients suffering from chronic kidney disease and end stage renal disease (ESRD). Headquartered in Denver, Colorado, the company operates a network of more than 2,800 outpatient dialysis centers across the United States, delivering hemodialysis and peritoneal dialysis treatments. DaVita’s portfolio also includes a range of supportive services such as vascular access management, laboratory diagnostics and nutritional counseling, all designed to optimize patient outcomes and quality of life.
In addition to its core in-center dialysis operations, DaVita offers comprehensive home dialysis solutions. Through its Home Therapies program, patients can choose daily home hemodialysis or peritoneal dialysis, supported by training, remote monitoring and specialized equipment. The company has invested in technology platforms and water purification systems to ensure treatment efficacy and safety, and it continues to explore telehealth innovations and mobile care units to extend access in underserved areas.
Founded in 1999 following a management-led buyout of the dialysis business of a major healthcare provider, DaVita traces its roots to pioneering efforts in the late 1970s to deliver outpatient renal therapy. Over the years, it has expanded beyond the U.S. into select international markets, including parts of Europe, Latin America and Asia Pacific, often forming partnerships with local hospitals and health systems to adapt its care model to regional regulations and patient needs.
DaVita is led by President and Chief Executive Officer Javier Rodriguez, who joined the company in 2016 and has held senior leadership roles spanning finance and operations. Under his guidance, DaVita has focused on patient-centered clinical programs, community outreach initiatives and strategic collaborations, positioning itself as a trusted provider in the evolving landscape of kidney care.
